In our study, MCC cells showing strong activation of the PI3K/AKT pathway were sensitive to the PI3K inhibitor LY-294002 in vitro although we cannot exclude that off target effects may contribute to the observed inhibition. The gene discussed is AKT1; the disease is Merkel cell skin cancer.